Page last updated: 2024-12-06

methylthymidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Methylthymidine, also known as thymidine monophosphate (TMP), is a nucleoside consisting of the pyrimidine base thymine attached to the 2-deoxyribose sugar. It is a crucial component of DNA, acting as a building block for the genetic code.

Methylthymidine synthesis involves the methylation of deoxyuridine monophosphate (dUMP) to TMP by the enzyme thymidylate synthase. This reaction is essential for DNA replication and repair.

Research on methylthymidine focuses on its role in various biological processes, including:
* DNA replication and repair
* Cancer development and treatment
* Viral infection and replication
* Cellular metabolism and signaling

Its importance stems from its direct involvement in DNA formation, which is critical for the proper functioning of all living organisms.

Methylthymidine is also studied for its potential therapeutic applications, such as:
* Development of antiviral drugs targeting viral DNA replication.
* Development of anti-cancer drugs that inhibit thymidylate synthase, thereby preventing tumor cell proliferation.

Further research on methylthymidine can provide deeper insights into the complex mechanisms of DNA replication, repair, and gene regulation, and may lead to the development of novel therapeutic strategies for various diseases.'

methylthymidine: RN given refers to N-3-methylthymidine [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID65062
CHEMBL ID1230115
CHEMBL ID160884
SCHEMBL ID2246880
MeSH IDM0059460

Synonyms (26)

Synonym
CHEMBL1230115
1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-3,5-dimethyl-pyrimidine-2,4-dione
n-3-(methyl)-thd
2,4(1h,3h)-pyrimidinedione, 1-(2-deoxy-.beta.-d-erythro-pentofuranosyl)-3,5-dimethyl-
methylthymidine
1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3,5-dimethylpyrimidine-2,4-dione
3-methylthymidine
chembl160884
1-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-3,5-dimethyl-1h-pyrimidine-2,4-dione
bdbm50028588
n3-methylthymidine
nsc-750726
958-74-7
n6kxy4l1jh ,
nsc 750726
unii-n6kxy4l1jh
thymidine, 3-methyl-
SCHEMBL2246880
DTXSID90241965
AKOS030530691
uridine, 2'-deoxy-3,5-dimethyl-
n-methylthymidine
3,5-dimethyldeoxyuridine
3-carboxymethylmorpholine-4-carboxylicacidtert-butylester
1-((2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3,5-dimethylpyrimidine-2,4(1h,3h)-dione
Q27453734

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Normal human serum produced a linear log dose-response with these serum concentrations."( Growth hormone dependent human serum stimulation of thymidine and sulphate incorporation into embryonic chicken cartilage.
Buchanan, F; Garland, JT; Jennings, J; Levitsky, L, 1980
)
0.26
" After dosing with the D-compound, the highest levels of radioactivity were found in the liver, kidneys, thymus, thyroid gland, and central nervous system, including the brain."( Pharmacokinetics and whole-body distribution of the new chemotherapeutic agent beta-D-glucosylisophosphoramide mustard and its effects on the incorporation of [methyl-3H]-thymidine in various tissues of the rat.
Bertram, B; Bollow, U; Hull, WE; Pohl, J; Port, R; Schaper, M; Stüben, J; Wiessler, M, 1996
)
0.29
" Dose-response curves were used to derive mathematically the EC3 value (the estimated concentration of chemical necessary to cause a stimulation index (SI) of 3 compared with proliferation induced by concurrent vehicle controls)."( The suitability of hexyl cinnamic aldehyde as a calibrant for the murine local lymph node assay.
Basketter, DA; Dearman, RJ; Gerberick, GF; Kimber, I; Ryan, CA; Wright, ZM, 2001
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Thymidine kinase, cytosolic Rattus norvegicus (Norway rat)Ki14,125.00002.40004.20006.5000AID126598; AID210886
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID210888Affinity towards cytoplasmic Thymidine kinase relative ot TdR.1982Journal of medicinal chemistry, Jun, Volume: 25, Issue:6
Species- or isozyme-specific enzyme inhibitors. 5. Differential effects of thymidine substituents on affinity for rat thymidine kinase isozymes.
AID233146Differential affinity is the ratio between M-TK and C-TK1982Journal of medicinal chemistry, Jun, Volume: 25, Issue:6
Species- or isozyme-specific enzyme inhibitors. 5. Differential effects of thymidine substituents on affinity for rat thymidine kinase isozymes.
AID126600Affinity towards mitochondrial thymidine kinase relative to TdR.1982Journal of medicinal chemistry, Jun, Volume: 25, Issue:6
Species- or isozyme-specific enzyme inhibitors. 5. Differential effects of thymidine substituents on affinity for rat thymidine kinase isozymes.
AID126598Non-competitive inhibition against rat mitochondrial thymidine kinase1982Journal of medicinal chemistry, Jun, Volume: 25, Issue:6
Species- or isozyme-specific enzyme inhibitors. 5. Differential effects of thymidine substituents on affinity for rat thymidine kinase isozymes.
AID210886Competitive inhibition against rat cytoplasmic Thymidine kinase1982Journal of medicinal chemistry, Jun, Volume: 25, Issue:6
Species- or isozyme-specific enzyme inhibitors. 5. Differential effects of thymidine substituents on affinity for rat thymidine kinase isozymes.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (79)

TimeframeStudies, This Drug (%)All Drugs %
pre-199026 (32.91)18.7374
1990's34 (43.04)18.2507
2000's12 (15.19)29.6817
2010's6 (7.59)24.3611
2020's1 (1.27)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 9.93

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index9.93 (24.57)
Research Supply Index4.43 (2.92)
Research Growth Index4.36 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (9.93)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.20%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other82 (98.80%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]